Intraarterial polidocanol injection for the treatment of peripheral arteriovenous malformations

Basit Öğe Kaydı
dc.contributor.authorErgun, Onur
dc.contributor.authorAtli, Eray
dc.contributor.authorGulek, Bozkurt
dc.contributor.authorCiftci, Turkmen
dc.contributor.authorCil, Barbaros
dc.contributor.authorVargel, Ibrahim
dc.contributor.authorPeynircioglu, Bora
dc.date.accessioned2020-06-25T18:12:11Z
dc.date.available2020-06-25T18:12:11Z
dc.date.issued2014
dc.departmentKırıkkale Üniversitesi
dc.descriptionPeynircioglu, Bora/0000-0002-1457-4721
dc.description.abstractThe purpose of this study was to investigate the efficacy and safety of intraarterial transcatheter administration of polidocanol as an alternative treatment for peripheral arteriovenous malformations (AVMs). The study comprised 10 patients (six males and four females) with a mean age of 28.8 years (range 8-52 years). All patients had trunk or extremity AVMs. Following the administration of general anesthesia or intravenous (IV) sedation, the patients underwent staged intraarterial polidocanol sclerotherapy with or without additional embolizations for their AVMs. The administration of polidocanol was executed by intraarterial infusion through a microcatheter or by direct percutaneous entry into the nidus under ultrasound guidance. A total of 19 sessions were accomplished in 10 patients. Polidocanol was used alone in six of the 19 sessions. In 13 sessions, polidocanol was used in combination with another agent (including n-butyl cyanoacrylate (NBCA), lipiodol, and ethanol) and/or coils. In two sessions, polidocanol was administered percutaneously under ultrasound guidance directly into the nidus documented by arteriography. No major complications occurred. Intraarterial transcatheter administration of polidocanol alone or in combination with other agents is a safe and effective alternative treatment for peripheral AVMs.en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1007/s00595-013-0680-8
dc.identifier.endpage1241en_US
dc.identifier.issn0941-1291
dc.identifier.issn1436-2813
dc.identifier.issue7en_US
dc.identifier.pmid23904047
dc.identifier.scopus2-s2.0-84903311077
dc.identifier.scopusqualityQ1
dc.identifier.startpage1232en_US
dc.identifier.urihttps://doi.org/10.1007/s00595-013-0680-8
dc.identifier.urihttps://hdl.handle.net/20.500.12587/5789
dc.identifier.volume44en_US
dc.identifier.wosWOS:000338031200007
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringeren_US
dc.relation.ispartofSurgery Today
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPolidocanolen_US
dc.subjectSclerotherapyen_US
dc.subjectArteriovenous malformationsen_US
dc.titleIntraarterial polidocanol injection for the treatment of peripheral arteriovenous malformationsen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Astrocytes, microglia macrophages, and neurons expressing Toll-like receptor 11 contribute to innate immunity against encephalitic Toxoplasma gondii infection.pdf
Boyut:
2.64 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu